Natural Killer Cell Therapeutics Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 49531 Report Format: PDF + Excel (Delivery in 48 Hrs)
1. Natural Killer Cell Therapeutics Market - Overview
        1.1 Definitions and Scope
2. Natural Killer Cell Therapeutics Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Natural Killer Cell Therapeutics Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Natural Killer Cell Therapeutics Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Natural Killer Cell Therapeutics Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Natural Killer Cell Therapeutics Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Natural Killer Cell Therapeutics Market -Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Natural Killer Cell Therapeutics Market - By End User (Market Size -$Million / $Billion)
8.1 Clinical Research Institute
8.2 Cancer Research Institute
8.3 Hospital
8.4 Other End User
9. Natural Killer Cell Therapeutics Market - By Therapeutic (Market Size -$Million / $Billion)
        9.1 Mogamulizumab
        9.2 Lorvotuzumab Mertansine
        9.3 Afm 13
        9.4 Fpa144
        9.5 Nktt-120
10. Natural Killer - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Gnant And Non-Gnant Cancer
                 10.3.1.1 Acute Myelogenous Leukemia
                 10.3.1.2 Kidney Cancer
                 10.3.1.3 Lung Cancer
            10.3.2 Immunotherapy
            10.3.3 Other Application
11. Natural Killer- By Geography (Market Size -$Million / $Billion)
        11.1 Natural Killer Cell Therapeutics Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Natural Killer- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Natural Killer- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Natural Killer - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Natural Killer - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Natural Killer Cell Therapeutics Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Natural Killer Cell Therapeutics Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Natural Killer Cell Therapeutics Market - Key Company List by Country Premium
15. Natural Killer Cell Therapeutics Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Affimed N V
        15.3 Celgene Corporation
        15.4 Fate Therapeutic
        15.5 Fortress Biotech
        15.6 Glycostem Therapeutic Bv
        15.7 Innate Pharma S A
        15.8 Nantkwest, Inc
        15.9 Nkarta, Inc
        15.10 Nkt Therapeutics, Inc
        15.11 Ziopharm Oncology, Inc
        15.12 Company 12
        15.13 Company 13 & More
*Financials would be provided on a best efforts basis for private companies
16. Natural Killer Cell Therapeutics Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Natural Killer Cell Therapeutics Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

LIST OF TABLES

1.Global Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 ($M)
1.1 Mogamulizumab Market 2019-2024 ($M) - Global Industry Research
1.2 Lorvotuzumab Mertansine Market 2019-2024 ($M) - Global Industry Research
1.3 Afm 13 Market 2019-2024 ($M) - Global Industry Research
1.4 Fpa144 Market 2019-2024 ($M) - Global Industry Research
1.5 Nktt-120 Market 2019-2024 ($M) - Global Industry Research
2.Global Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 ($M)
2.1 Clinical Research Institute Market 2019-2024 ($M) - Global Industry Research
2.2 Cancer Research Institute Market 2019-2024 ($M) - Global Industry Research
2.3 Hospital Market 2019-2024 ($M) - Global Industry Research
3.Global Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 (Volume/Units)
3.1 Mogamulizumab Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Lorvotuzumab Mertansine Market 2019-2024 (Volume/Units) - Global Industry Research
3.3 Afm 13 Market 2019-2024 (Volume/Units) - Global Industry Research
3.4 Fpa144 Market 2019-2024 (Volume/Units) - Global Industry Research
3.5 Nktt-120 Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 (Volume/Units)
4.1 Clinical Research Institute Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Cancer Research Institute Market 2019-2024 (Volume/Units) - Global Industry Research
4.3 Hospital Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 ($M)
5.1 Mogamulizumab Market 2019-2024 ($M) - Regional Industry Research
5.2 Lorvotuzumab Mertansine Market 2019-2024 ($M) - Regional Industry Research
5.3 Afm 13 Market 2019-2024 ($M) - Regional Industry Research
5.4 Fpa144 Market 2019-2024 ($M) - Regional Industry Research
5.5 Nktt-120 Market 2019-2024 ($M) - Regional Industry Research
6.North America Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 ($M)
6.1 Clinical Research Institute Market 2019-2024 ($M) - Regional Industry Research
6.2 Cancer Research Institute Market 2019-2024 ($M) - Regional Industry Research
6.3 Hospital Market 2019-2024 ($M) - Regional Industry Research
7.South America Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 ($M)
7.1 Mogamulizumab Market 2019-2024 ($M) - Regional Industry Research
7.2 Lorvotuzumab Mertansine Market 2019-2024 ($M) - Regional Industry Research
7.3 Afm 13 Market 2019-2024 ($M) - Regional Industry Research
7.4 Fpa144 Market 2019-2024 ($M) - Regional Industry Research
7.5 Nktt-120 Market 2019-2024 ($M) - Regional Industry Research
8.South America Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 ($M)
8.1 Clinical Research Institute Market 2019-2024 ($M) - Regional Industry Research
8.2 Cancer Research Institute Market 2019-2024 ($M) - Regional Industry Research
8.3 Hospital Market 2019-2024 ($M) - Regional Industry Research
9.Europe Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 ($M)
9.1 Mogamulizumab Market 2019-2024 ($M) - Regional Industry Research
9.2 Lorvotuzumab Mertansine Market 2019-2024 ($M) - Regional Industry Research
9.3 Afm 13 Market 2019-2024 ($M) - Regional Industry Research
9.4 Fpa144 Market 2019-2024 ($M) - Regional Industry Research
9.5 Nktt-120 Market 2019-2024 ($M) - Regional Industry Research
10.Europe Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 ($M)
10.1 Clinical Research Institute Market 2019-2024 ($M) - Regional Industry Research
10.2 Cancer Research Institute Market 2019-2024 ($M) - Regional Industry Research
10.3 Hospital Market 2019-2024 ($M) - Regional Industry Research
11.APAC Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 ($M)
11.1 Mogamulizumab Market 2019-2024 ($M) - Regional Industry Research
11.2 Lorvotuzumab Mertansine Market 2019-2024 ($M) - Regional Industry Research
11.3 Afm 13 Market 2019-2024 ($M) - Regional Industry Research
11.4 Fpa144 Market 2019-2024 ($M) - Regional Industry Research
11.5 Nktt-120 Market 2019-2024 ($M) - Regional Industry Research
12.APAC Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 ($M)
12.1 Clinical Research Institute Market 2019-2024 ($M) - Regional Industry Research
12.2 Cancer Research Institute Market 2019-2024 ($M) - Regional Industry Research
12.3 Hospital Market 2019-2024 ($M) - Regional Industry Research
13.MENA Natural Killer Cell Therapeutic Market, By Therapeutic Market 2019-2024 ($M)
13.1 Mogamulizumab Market 2019-2024 ($M) - Regional Industry Research
13.2 Lorvotuzumab Mertansine Market 2019-2024 ($M) - Regional Industry Research
13.3 Afm 13 Market 2019-2024 ($M) - Regional Industry Research
13.4 Fpa144 Market 2019-2024 ($M) - Regional Industry Research
13.5 Nktt-120 Market 2019-2024 ($M) - Regional Industry Research
14.MENA Natural Killer Cell Therapeutic Market, By End User Market 2019-2024 ($M)
14.1 Clinical Research Institute Market 2019-2024 ($M) - Regional Industry Research
14.2 Cancer Research Institute Market 2019-2024 ($M) - Regional Industry Research
14.3 Hospital Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Natural Killer Market Revenue, 2019-2024 ($M)
2.Canada Natural Killer Market Revenue, 2019-2024 ($M)
3.Mexico Natural Killer Market Revenue, 2019-2024 ($M)
4.Brazil Natural Killer Market Revenue, 2019-2024 ($M)
5.Argentina Natural Killer Market Revenue, 2019-2024 ($M)
6.Peru Natural Killer Market Revenue, 2019-2024 ($M)
7.Colombia Natural Killer Market Revenue, 2019-2024 ($M)
8.Chile Natural Killer Market Revenue, 2019-2024 ($M)
9.Rest of South America Natural Killer Market Revenue, 2019-2024 ($M)
10.UK Natural Killer Market Revenue, 2019-2024 ($M)
11.Germany Natural Killer Market Revenue, 2019-2024 ($M)
12.France Natural Killer Market Revenue, 2019-2024 ($M)
13.Italy Natural Killer Market Revenue, 2019-2024 ($M)
14.Spain Natural Killer Market Revenue, 2019-2024 ($M)
15.Rest of Europe Natural Killer Market Revenue, 2019-2024 ($M)
16.China Natural Killer Market Revenue, 2019-2024 ($M)
17.India Natural Killer Market Revenue, 2019-2024 ($M)
18.Japan Natural Killer Market Revenue, 2019-2024 ($M)
19.South Korea Natural Killer Market Revenue, 2019-2024 ($M)
20.South Africa Natural Killer Market Revenue, 2019-2024 ($M)
21.North America Natural Killer By Application
22.South America Natural Killer By Application
23.Europe Natural Killer By Application
24.APAC Natural Killer By Application
25.MENA Natural Killer By Application
26.Nkarta, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Fortress Biotech, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Celgene Corporation, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Fate Therapeutic, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Nantkwest, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Glycostem Therapeutic Bv, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.Ziopharm Oncology, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Affimed N V, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Innate Pharma S A, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Nkt Therapeutics, Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)